These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17823293)

  • 1. Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.
    Jackson SW; Hoshi T; Wu Y; Sun X; Enjyoji K; Cszimadia E; Sundberg C; Robson SC
    Am J Pathol; 2007 Oct; 171(4):1395-404. PubMed ID: 17823293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/ENTPD1 null mice.
    Sun X; Han L; Seth P; Bian S; Li L; Csizmadia E; Junger WG; Schmelzle M; Usheva A; Tapper EB; Baffy G; Sukhatme VP; Wu Y; Robson SC
    Hepatology; 2013 Jan; 57(1):205-16. PubMed ID: 22859060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of cd39/entpd1 results in hepatic insulin resistance.
    Enjyoji K; Kotani K; Thukral C; Blumel B; Sun X; Wu Y; Imai M; Friedman D; Csizmadia E; Bleibel W; Kahn BB; Robson SC
    Diabetes; 2008 Sep; 57(9):2311-20. PubMed ID: 18567823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of expression of human ecto-nucleoside triphosphate diphosphohydrolase-1 and/or ecto-5'-nucleotidase in pig endothelial cells.
    De Giorgi M; Pelikant-Malecka I; Sielicka A; Slominska EM; Giovannoni R; Cinti A; Cerrito MG; Lavitrano M; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):313-8. PubMed ID: 24940685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disordered cellular migration and angiogenesis in cd39-null mice.
    Goepfert C; Sundberg C; Sévigny J; Enjyoji K; Hoshi T; Csizmadia E; Robson S
    Circulation; 2001 Dec; 104(25):3109-15. PubMed ID: 11748109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration.
    Beldi G; Wu Y; Sun X; Imai M; Enjyoji K; Csizmadia E; Candinas D; Erb L; Robson SC
    Gastroenterology; 2008 Nov; 135(5):1751-60. PubMed ID: 18804472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
    Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
    Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
    Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
    Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
    Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
    Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice.
    Künzli BM; Nuhn P; Enjyoji K; Banz Y; Smith RN; Csizmadia E; Schuppan D; Berberat PO; Friess H; Robson SC
    Gastroenterology; 2008 Jan; 134(1):292-305. PubMed ID: 18036594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
    J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.
    Enjyoji K; Sévigny J; Lin Y; Frenette PS; Christie PD; Esch JS; Imai M; Edelberg JM; Rayburn H; Lech M; Beeler DL; Csizmadia E; Wagner DD; Robson SC; Rosenberg RD
    Nat Med; 1999 Sep; 5(9):1010-7. PubMed ID: 10470077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation.
    Robson SC; Wu Y; Sun X; Knosalla C; Dwyer K; Enjyoji K
    Semin Thromb Hemost; 2005 Apr; 31(2):217-33. PubMed ID: 15852225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical and functional analysis of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) and ecto-5'-nucleotidase (CD73) in pig aortic valves.
    Kaniewska E; Sielicka A; Sarathchandra P; Pelikant-Małecka I; Olkowicz M; Słomińska EM; Chester AH; Yacoub MH; Smoleński RT
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):305-12. PubMed ID: 24940684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice.
    Sun X; Wu Y; Gao W; Enjyoji K; Csizmadia E; Müller CE; Murakami T; Robson SC
    Gastroenterology; 2010 Sep; 139(3):1030-40. PubMed ID: 20546740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic dysregulation in pulmonary hypertension.
    Visovatti SH; Hyman MC; Goonewardena SN; Anyanwu AC; Kanthi Y; Robichaud P; Wang J; Petrovic-Djergovic D; Rattan R; Burant CF; Pinsky DJ
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H286-98. PubMed ID: 27208163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy.
    Friedman DJ; Rennke HG; Csizmadia E; Enjyoji K; Robson SC
    Diabetes; 2007 Sep; 56(9):2371-9. PubMed ID: 17473221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD39 is incorporated into plasma microparticles where it maintains functional properties and impacts endothelial activation.
    Banz Y; Beldi G; Wu Y; Atkinson B; Usheva A; Robson SC
    Br J Haematol; 2008 Aug; 142(4):627-37. PubMed ID: 18537971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors.
    Schaefer U; Machida T; Broekman MJ; Marcus AJ; Levi R
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1269-77. PubMed ID: 17565006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets.
    Atkinson B; Dwyer K; Enjyoji K; Robson SC
    Blood Cells Mol Dis; 2006; 36(2):217-22. PubMed ID: 16476557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.